AKBAAkebia Therapeutics, Inc.$0.84-7.24%
WAIT.
A falling knife — never catch it mid-drop.
The stock is still dropping hard on heavy volume with no support underneath. 4 of 4 entry triggers may be firing, but a live slide overrides them — that is exactly the setup this check exists for. It does not call the bottom; it says the drop is not finished.
QTick signal
-3net
0 bull / 2 bear factors · leaningBull 1 pts·Bear 4 pts30d
4 of 4 aligned — not yet
A falling knife — the guard overrides the entry triggers.
Market context—Sector read · not on fileRiskBalance sheet · Distress—PCE sensitivity · not on fileRiskFalling-knife phase · 100/100 · was 2 on Aug 60/6Bottom watch · 0 of 6 confirmations
Chart pattern
Death cross
50d below 200d · bearish structure
Volume vs 20-day avg1.62× · 8.42M vs 5.21M avg
52-week range$0.82 – $3.44
Below high since 2015-96.0% · $21.22 high
Risk / reward—
Plan stop—
Max pain—
RSI 1425.1 oversold
Forensic flags1 review
What-if price
$0.84
$0.68 · -20.0%-20.0%move the price to stress-test the setupdrag to test another price+21.7% · $1.03+21.7%
Entry strategy · 10 triggers4 of 4 aligned — not yet
RSI 14✓
25.1
oversold
vs 50-day✓
$1.15
below the line
Bollinger✓
$0.94
lower-band pierce
VWAP 20✓
$1.12
below the rolling VWAP
Entry level●
—
not on file
Put wall●
—
not on file
MACD●
-0.06
below zero · still falling
RVolStatic
1.62×
elevated versus recent average
Short int.Static
7.2%
short interest below 20%
ATRStatic
$0.09
14-session average true range
A checklist, not odds on a return: 3 of 4 usable price conditions have to line up. RSI, the 50-day average and the Bollinger band move with the price you set; the 20-day average traded price, the entry level and the busiest put strike stay fixed. MACD, relative volume and short interest are context only — they never count toward the total.
Next earnings
9 Nov 2026 · after the bell
amc · in 89 days
Next dividend
No indicated yield
no forward dividend on file